Skip to main content

Advertisement

Log in

Uterine Fibroids, Race, Ethnicity, and Cardiovascular Outcomes

  • Race and Ethnicity Disparities (M. Albert, Section Editor)
  • Published:
Current Cardiovascular Risk Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Uterine fibroids are the cause of significant morbidity for women particularly women of racial and ethnic minorities. This review seeks to draw connections between fibroids and another cause of morbidity and mortality, cardiovascular disease. Fibroids are the most common neoplasm affecting women as well as the most common reason for undergoing hysterectomy. Heart disease is the leading cause of death for women in the USA, and heart disease and stroke disproportionately impact women of racial and ethnic minorities.

Recent Findings

Prospective studies in the last several years have revealed a higher prevalence of metabolic syndrome and other clinical and subclinical manifestations of cardiovascular disease in women with fibroids.

Summary

Study of the clinical and subclinical manifestations of each disease state may set the foundation for both preventative and therapeutic interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

BMI:

Body mass index

BWHS:

Black Women’s Health Study

CVD:

Cardiovascular disease

MI:

Myocardial infarction

NSQIP:

National Surgical Quality Improvement Program

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. Chang M-H, Moonesinghe R, Athar HM, Truman BI. Trends in disparity by sex and race/ethnicity for the leading causes of death in the United States-1999-2010. J Public Health Manag Pract. 2016;22(Suppl 1):S13–24.

    Article  Google Scholar 

  2. Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG An Int J Obstet Gynaecol. 2017;124:1501–12.

    Article  CAS  Google Scholar 

  3. Ghidei L, Murray A, Singer J. Race, research, and women’s health: best practice guidelines for investigators. Obstet Gynecol. 2019;133:815–8.

    PubMed  Google Scholar 

  4. Hoffman BL, Schorge JO, Bradshaw KD, Halvorson LM, Schaffer JI, Corton MM (2016) Pelvic mass. Williams Gynecol. 3e.

  5. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188:100–7.

    Article  Google Scholar 

  6. Peddada SD, Laughlin SK, Miner K, Guyon JP, Haneke K, Vahdat HL, et al. Growth of uterine leiomyomata among premenopausal black and white women. Proc Natl Acad Sci U S A. 2008;105:19887–92.

    Article  CAS  Google Scholar 

  7. Tal R, Segars JH. The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy. Hum Reprod Update. 2014;20:194–216. https://doi.org/10.1093/humupd/dmt042.

    Article  CAS  PubMed  Google Scholar 

  8. Moss NS, Benditt EP. Human atherosclerotic plaque cells and leiomyoma cells. Comparison of in vitro growth characteristics. Am J Pathol. 1975;78:175–90.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Silver MA, Raghuvir R, Fedirko B, Elser D. Systemic hypertension among women with uterine leiomyomata: potential final common pathways of target end-organ remodeling. J Clin Hypertens (Greenwich). 2005;7:664–8.

    Article  Google Scholar 

  10. Malik M, Norian J, McCarthy-Keith D, Britten J, Catherino WH. Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women. Semin Reprod Med. 2010;28:169–79.

    Article  Google Scholar 

  11. Leppert PC, Catherino WH, Segars JH. A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays. Am J Obstet Gynecol. 2006;195:415–20.

    Article  CAS  Google Scholar 

  12. Settnes A, Andreasen AH, Jørgensen T. Hypertension is associated with an increased risk for hysterectomy. Eur J Obstet Gynecol Reprod Biol. 2005;122:218–24.

    Article  Google Scholar 

  13. Sengoba KS, Ghant MS, Okeigwe I, Mendoza G, Marsh EE. Racial/ethnic differences in women’s experiences with symptomatic uterine fibroids: a qualitative assessment. J racial Ethn Heal disparities. 2017;4:178–83.

    Article  Google Scholar 

  14. Marsh EE, Al-Hendy A, Kappus D, Galitsky A, Stewart EA, Kerolous M. Burden, prevalence, and treatment of uterine fibroids: a survey of U.S. women. J Women's Health (Larchmt). 2018;27:1359–67.

    Article  Google Scholar 

  15. Wright JD, Herzog TJ, Tsui J, Ananth CV, Lewin SN, Lu Y-S, et al. Nationwide trends in the performance of inpatient hysterectomy in the United States. Obstet Gynecol. 2013;122:233–41.

    Article  Google Scholar 

  16. Price JT, Zimmerman LD, Koelper NC, Sammel MD, Lee S, Butts SF. Social determinants of access to minimally invasive hysterectomy: reevaluating the relationship between race and route of hysterectomy for benign disease. Am J Obstet Gynecol. 2017;217:572.e1–572.e10.

    Article  Google Scholar 

  17. Alexander AL, Strohl AE, Rieder S, Holl J, Barber EL. Examining disparities in route of surgery and postoperative complications in black race and hysterectomy. Obstet Gynecol. 2019;133:6–12.

    Article  Google Scholar 

  18. •• Haan YC, Diemer FS, Van Der Woude L, Van Montfrans GA, Oehlers GP, Brewster LM. The risk of hypertension and cardiovascular disease in women with uterine fibroids. J Clin Hypertens. 2018;20:718–26 Haan et al. performed a cross-sectional study of women with self-reported fibroids. They demonstrated that women with fibroids were 3.4 times more likely to have hypertension, 1.7 times more likely to have diabetes, and 1.8 times more likely to have hypercholesterolemia. When adjusted for confounders, women remained 1.8 times more likely to develop hypertension if they had fibroids as well. Asymptomatic end organ damage occurred significantly more often in younger women with fibroids.

    Article  Google Scholar 

  19. Boynton-Jarrett R, Rich-Edwards J, Malspeis S, Missmer SA, Wright R. A prospective study of hypertension and risk of uterine leiomyomata HHS public access. Am J Epidemiol. 2005;161:628–38.

    Article  Google Scholar 

  20. Aksoy Y, Sivri N, Karaoz B, Sayin C, Yetkin E. Carotid intima-media thickness: a new marker of patients with uterine leiomyoma. Eur J Obstet Gynecol Reprod Biol. 2014;175:54–7.

    Article  Google Scholar 

  21. Korkmaz V, Ozkaya E, Özer Kadife S, Kara F, Kucukozkan T. Investigation of cardiovascular disease risk in women with uterine leiomyomas. Ir J Med Sci. 2016;185:689–93.

    Article  CAS  Google Scholar 

  22. •• Uimari O, Auvinen J, Jokelainen J, Puukka K, Ruokonen A, Järvelin M-R, et al. Uterine fibroids and cardiovascular risk. Hum Reprod. 2016;31:2689–703 Uimari et al. performed an analysis of a long-term Finnish cohort followed for 45 years. They correlated incremental increases in LDL and cholesterol levels with increased risk of diagnosis of fibroids. They also noted an increased risk of fibroids with increased waist-hip ratio. A diagnosis of metabolic syndrome increased risk of diagnosis of fibroids.

    Article  Google Scholar 

  23. Laughlin-Tommaso SK, Fuchs EL, Wellons MF, Lewis CE, Calderon-Margalit R, Stewart EA, et al. Uterine fibroids and the risk of cardiovascular disease in the coronary artery risk development in young adult women’s study. J Women's Health. 2018;28:46–52.

    Article  Google Scholar 

  24. Radin RG, Rosenberg L, Palmer JR, Cozier YC, Kumanyika SK, Wise LA. Hypertension and risk of uterine leiomyomata in US black women. Hum Reprod. 2012;27:1504–9.

    Article  CAS  Google Scholar 

  25. Ding D-C, Tsai I-J, Hsu C, Wang J-H, Lin S-Z, Sung F-C. Risk of hypertension after hysterectomy: a population-based study. BJOG An Int J Obstet Gynaecol. 2018;125:1717–24.

    Article  CAS  Google Scholar 

  26. Laughlin-Tommaso SK, Khan Z, Weaver AL, Smith CY, Rocca WA, Stewart EA. Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation. Menopause. 2017;25:1.

    Google Scholar 

  27. Erekson EA, Martin DK, Ratner ES. Oophorectomy: the debate between ovarian conservation and elective oophorectomy. Menopause. 2013;20:110–4.

    Article  Google Scholar 

  28. Laughlin-Tommaso SK, Khan Z, Weaver AL, Schleck CD, Rocca WA, Stewart EA. Cardiovascular risk factors and diseases in women undergoing hysterectomy with ovarian conservation. Menopause. 2016;23:121–8.

    Article  Google Scholar 

  29. Meyer IH. Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: conceptual issues and research evidence. Psychol Bull. 2003;129:674–97.

    Article  Google Scholar 

  30. Vines AI, Ta M, Esserman DA. The association between self-reported major life events and the presence of uterine fibroids. Womens Health Issues. 2010;20:294–8 [1].

    Article  Google Scholar 

  31. Hellwege JN, Torstenson ES, Russell SB, Edwards TL, Velez Edwards DR. Evidence of selection as a cause for racial disparities in fibroproliferative disease. PLoS One. 2017;12:e0182791.

    Article  Google Scholar 

  32. Saban KL, Mathews HL, Bryant FB, Tell D, Joyce C, DeVon HA, et al. Perceived discrimination is associated with the inflammatory response to acute laboratory stress in women at risk for cardiovascular disease. Brain Behav Immun. 2018;73:625–32.

    Article  CAS  Google Scholar 

  33. Cunningham TJ, Seeman TE, Kawachi I, Gortmaker SL, Jacobs DR, Kiefe CI, et al. Racial/ethnic and gender differences in the association between self-reported experiences of racial/ethnic discrimination and inflammation in the CARDIA cohort of 4 US communities. Soc Sci Med. 2012;75:922–31.

    Article  Google Scholar 

  34. Korous KM, Causadias JM, Casper DM. Racial discrimination and cortisol output: a meta-analysis. Soc Sci Med. 2017;193:90–100.

    Article  Google Scholar 

  35. Burroughs Peña MS, Mbassa RS, Slopen NB, Williams DR, Buring JE, Albert MA. Cumulative psychosocial stress and ideal cardiovascular health in older women. Circulation. 2019;139:2012–21.

    Article  Google Scholar 

  36. Saban KL, Tell D, Janusek L. Resilience in African American women at risk for cardiovascular disease: an exploratory study. J Urban Heal. 2019;96:44–9.

    Article  Google Scholar 

  37. Wise LA, Palmer JR, Cozier YC, Hunt MO, Stewart EA, Rosenberg L. Perceived racial discrimination and risk of uterine leiomyomata. Epidemiology. 2007;18:747–57.

    Article  Google Scholar 

  38. Vidaeff A, Pettker CM, Simhan H. Gestational hypertension and preeclampsia ACOG PRACTICE BULLETIN. Clinical Management Guidelines for Obstetrician-Gynecologists Am Coll Obstet Gynecol. (2019);133:1–25.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nyia L. Noel.

Ethics declarations

Conflict of Interest

Nyia L. Noel is a consultant for OBP Medical. Paul Hendessi is a consultant for Medtronic. Alexis Gadson declares that she has no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Race and Ethnicity Disparities

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Noel, N.L., Gadson, A.K. & Hendessi, P. Uterine Fibroids, Race, Ethnicity, and Cardiovascular Outcomes. Curr Cardiovasc Risk Rep 13, 28 (2019). https://doi.org/10.1007/s12170-019-0622-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s12170-019-0622-0

Keywords

Navigation